pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

2,566 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 213 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: 8k filing×type: filing×type: pdufa×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa213
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Ophthalmology5
    • Dermatology1
    • Infectious Disease1

    Week of Jun 29, 2026

    50
    ›Jun 29, 20268k filing24d ago$FDMT — 4D Molecular Therapeutics, Inc. (FDMT) — 8-K filing

    Items: 1.01, 2.03

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$ZYME — Zymeworks Inc. (ZYME) — 8-K filing

    Items: 1.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$RGNX — REGENXBIO Inc. (RGNX) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$LRMR — Larimar Therapeutics, Inc. (LRMR) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$IKT — Inhibikase Therapeutics, Inc. (IKT) — 8-K filing

    Items: 5.02, 5.03, 5.07, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$DCOY — Decoy Therapeutics Inc. (DCOY) — 8-K filing

    Items: 1.01, 3.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$VRDN — Viridian Therapeutics, Inc.\DE (VRDN) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$BYSI — BeyondSpring Inc. (BYSI) — 8-K filing

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$BCRX — BIOCRYST PHARMACEUTICALS INC (BCRX) — 8-K filing

    Items: 2.05, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$UTHR — UNITED THERAPEUTICS Corp (UTHR) — 8-K filing

    Items: 5.02, 5.07, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$GANX — Gain Therapeutics, Inc. (GANX) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$BDTX — Black Diamond Therapeutics, Inc. (BDTX) — 8-K filing

    Items: 5.07

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d agoACURA PHARMACEUTICALS, INC — 8-K filing

    Items: 1.01, 2.01, 2.03, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$NVCT — Nuvectis Pharma, Inc. (NVCT) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$MMED — MiniMed Group, Inc. (MMED) — 8-K filing

    Items: 5.02, 5.08, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$REPL — Replimune Group, Inc. (REPL) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$ALMS — ALUMIS INC. (ALMS) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 29, 20268k filing24d ago$TBPH — Theravance Biopharma, Inc. (TBPH) — 8-K filing

    Items: 1.01, 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$XERS — Xeris Biopharma Holdings, Inc. (XERS) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$RANI — Rani Therapeutics Holdings, Inc. (RANI) — 8-K filing

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$NVCR — NovoCure Ltd (NVCR) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$VTGN — Vistagen Therapeutics, Inc. (VTGN) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$PCRX — Pacira BioSciences, Inc. (PCRX) — 8-K filing

    Items: 1.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$PRGO — PERRIGO Co plc (PRGO) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$NUMD — Nu-Med Plus, Inc. (NUMD) — 8-K filing

    Items: 1.01, 3.02, 3.03, 5.03, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$AKBA — Akebia Therapeutics, Inc. (AKBA) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$KAPA — Kairos Pharma, LTD. (KAPA) — 8-K filing

    Items: 5.07

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d agobioAffinity Technologies, Inc. (BIAF, BIAFW) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$JUNS — JUPITER NEUROSCIENCES, INC. (JUNS) — 8-K filing

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$RNXT — RenovoRx, Inc. (RNXT) — 8-K filing

    Items: 5.07, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$IMNN — Imunon, Inc. (IMNN) — 8-K filing

    Items: 5.02, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d agoCelularity Inc (CELU, CELUW) — 8-K filing

    Items: 1.01, 2.03, 5.02, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$MBOT — Microbot Medical Inc. (MBOT) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$HCWB — HCW Biologics Inc. (HCWB) — 8-K filing

    Items: 3.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$MBRX — Moleculin Biotech, Inc. (MBRX) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$MBRX — Moleculin Biotech, Inc. (MBRX) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$MNPR — Monopar Therapeutics (MNPR) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$PBH — Prestige Consumer Healthcare Inc. (PBH) — 8-K filing

    Items: 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d agoEstrella Immunopharma, Inc. (ESLA, ESLAW) — 8-K filing

    Items: 5.07

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$ORMP — ORAMED PHARMACEUTICALS INC. (ORMP) — 8-K filing

    Items: 5.03, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$SSII — SS Innovations International, Inc. (SSII) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$NUVB — Nuvation Bio Inc. (NUVB) — 8-K filing

    Items: 1.01, 1.02, 2.03, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d agoALLURION TECHNOLOGIES, INC. (ALUR, ALURW) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$CPRX — CATALYST PHARMACEUTICALS, INC. (CPRX) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$TENX — TENAX THERAPEUTICS, INC. (TENX) — 8-K filing

    Items: 1.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$SEPN — Septerna, Inc. (SEPN) — 8-K filing

    Items: 5.07

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$IRON — Disc Medicine, Inc. (IRON) — 8-K filing

    Items: 1.01, 2.03

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$APVO — Aptevo Therapeutics Inc. (APVO) — 8-K filing

    Items: 1.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$ALXO — ALX ONCOLOGY HOLDINGS INC (ALXO) — 8-K filing

    Items: 5.02, 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jun 30, 20268k filing23d ago$XCUR — EXICURE, INC. (XCUR) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ← prev
    page 43 of 52
    next →